ASPP proteins specifically stimulate the apoptotic function of p53

被引：632

作者：

Samuels-Lev, Y ^{[1
]}

O'Connor, DJ ^{[1
]}

Bergamaschi, D ^{[1
]}

Trigiante, G ^{[1
]}

Hsieh, JK ^{[1
]}

Zhong, S ^{[1
]}

Campargue, I ^{[1
]}

Naumovski, L ^{[1
]}

Crook, T ^{[1
]}

Lu, X ^{[1
]}

机构：

[1] Univ London Imperial Coll Sci & Technol, Sch Med, Ludwig Inst Canc Res, London W2 1PG, England

来源：

MOLECULAR CELL | 2001年 / 8卷 / 04期

关键词：

D O I：

10.1016/S1097-2765(01)00367-7

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

We identified a family of proteins termed ASPP. ASPP1 is a protein homologous to 53BP2, the C-terminal half of ASPP2. ASPP proteins interact with p53 and specifically enhance p53-induced apoptosis but not cell cycle arrest. Inhibition of endogenous ASPP function suppresses the apoptotic function of endogenous p53 in response to apoptotic stimuli. ASPP enhance the DNA binding and transactivation function of p53 on the promoters of proapoptotic genes in vivo. Two tumor-derived p53 mutants with reduced apoptotic function were defective in cooperating with ASPP in apoptosis induction. The expression of ASPP is frequently downregulated in human breast carcinomas expressing wild-type p53 but not mutant p53. Therefore, ASPP regulate the tumor suppression function of p53 in vivo.

引用

页码：781 / 794

页数：14

共 22 条

[1]

[Anonymous], 1988, Antibodies: A Laboratory Manual

[2] p53 mutation with frequent novel codons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours [J].

Crook, T ;

Brooks, LA ;

Crossland, S ;

Osin, P ;

Barker, KT ;

Waller, J ;

Philp, E ;

Smith, PD ;

Yulug, I ;

Peto, J ;

Parker, G ;

Allday, MJ ;

Crompton, MR ;

Gusterson, BA .

ONCOGENE, 1998, 17 (13) :1681-1689

[3]

Friedlander P, 1996, MOL CELL BIOL, V16, P4961

[4] THE LOCUS OF THE POLYMORPHIC EPITHELIAL MUCIN (PEM) TUMOR-ANTIGEN ON CHROMOSOME 1Q21 SHOWS A HIGH-FREQUENCY OF ALTERATION IN PRIMARY HUMAN BREAST-TUMORS [J].

GENDLER, SJ ;

COHEN, EP ;

CRASTON, A ;

DUHIG, T ;

JOHNSTONE, G ;

BARNES, D .

INTERNATIONAL JOURNAL OF CANCER, 1990, 45 (03) :431-435

[5] Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2 [J].

Gorina, S ;

Pavletich, NP .

SCIENCE, 1996, 274 (5289) :1001-1005

[6] Protein phosphatase 1 interacts with p53BP2, a protein which binds to the tumour suppressor p53 [J].

Helps, NR ;

Barker, HM ;

Elledge, SJ ;

Cohen, PTW .

FEBS LETTERS, 1995, 377 (03) :295-300

[7] E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction [J].

Hsieh, JK ;

Fredersdorf, S ;

Kouzarides, T ;

Martin, K ;

Lu, X .

GENES & DEVELOPMENT, 1997, 11 (14) :1840-1852

[8] 2 CELLULAR PROTEINS THAT BIND TO WILD-TYPE BUT NOT MUTANT P53 [J].

IWABUCHI, K ;

BARTEL, PL ;

LI, B ;

MARRACCINO, R ;

FIELDS, S .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (13) :6098-6102

[9] Stimulation of p53-mediated transcriptional activation by the p53-binding proteins, 53BP1 and 53BP2 [J].

Iwabuchi, K ;

Li, B ;

Massa, HF ;

Trask, BJ ;

Date, T ;

Fields, S .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (40) :26061-26068

[10] p53: Puzzle and paradigm [J].

Ko, LJ ;

Prives, C .

GENES & DEVELOPMENT, 1996, 10 (09) :1054-1072

← 1 2 3 →